Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 2 subfamily AC member 1, pseudogene (CYP2AC1P) is a human pseudogene of the cytochrome P450 superfamily[5][6]. Pseudogenes are non-functional segments of DNA that resemble functional genes but, due to mutations or deletions, do not produce functional proteins[5][3][6]. CYP2AC1P has no known enzyme activity and is not known to influence metabolism, drug response, or disease directly as a coding gene. It should not be treated as a therapeutic target. There is no evidence that it encodes a protein or interacts with drugs[5][6]. The broader **cytochrome P450 family (CYPs)** comprises heme-containing enzymes that participate in drug metabolism and the synthesis of cholesterol, steroids, and other lipids, and many functional CYPs are important clinical drug targets or pharmacogenomic factors[1][7]. However, **CYP2AC1P itself is not among these functional enzymes**. The entry is sometimes parsed as a target due to its name, but as a *pseudogene*, it does not produce an active protein and thus does not serve as a drug target. Catalogues such as GeneCards, HGNC, and primary literature recognize the functional status of CYP2AC1P as a pseudogene—not a pharmacologically relevant gene[5][6]. No known aliases besides official gene/protein nomenclature apply to this pseudogene. As a pseudogene, it does not produce an active protein/nucleic acid and should not be considered a valid molecular target for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 2 subfamily AC member 1, pseudogene (CYP2AC1P).